(Report ID: 126061) Drug interactions analysis of:
Lunesta, Valsartan, Restoril, Ativan, Levoxyl, Zoloft, CoumadinMany drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,579 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 6 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk. Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 126061 | Apr, 2, 2006 | 79 | Female |
List of drugs the patient takes:
| Drug |
Lunesta |
Valsartan |
Restoril |
Ativan |
Levoxyl |
Zoloft |
Coumadin |
| Name |
Blood Pressure Increased |
Drug Ineffective |
Insomnia |
Results from eHealthMe: 6 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Blood Pressure Increased | 1 (16.67%) |
Drug Ineffective | 1 (16.67%) |
Insomnia | 1 (16.67%) |
3) Top co-used drugs drugs reported for the past 12 months:
Death: 0
Cancer: 0
| Name | Count (% of total reports) |
1 | Hip Fracture | 3 (50.00%) |
2 | Gastrointestinal Haemorrhage | 3 (50.00%) |
3 | Pulmonary Embolism | 3 (50.00%) |
4 | Supraventricular Tachycardia | 3 (50.00%) |
5 | Syncope | 3 (50.00%) |
6 | Fall | 3 (50.00%) |
7 | Coagulopathy | 3 (50.00%) |
8 | Haemorrhoids | 2 (33.33%) |
9 | Hypotension | 2 (33.33%) |
10 | Oedema Peripheral | 2 (33.33%) |
| Name | Count |
1 | Vicodin | 6 |
2 | Compazine | 6 |
3 | Lactulose | 5 |
4 | Lasix | 4 |
5 | Cardizem Cd | 3 |
6 | Protonix | 3 |
7 | Antivert | 3 |
8 | Diovan | 3 |
9 | Multi-vitamin | 3 |
10 | Megace | 3 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|
